Bandingkan Harga & Kinerja Budi Starch Sweetener Tbk (BUDI) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Budi Starch Sweetener Tbk dan UBC Medical Indonesia Tbk.: Budi Starch Sweetener Tbk diperdagangkan di Rp206 (kapitalisasi pasar 935,79 M, volume 24 jam 20,1 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Budi Starch Sweetener Tbk lebih besar dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (817,3 rb vs 20,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BUDI | LABS | |
|---|---|---|
Kapitalisasi Pasar | 935,79 M | 584,6 M |
Volume | 20,1 rb | 817,3 rb |
Lot | 201 | 8,17 rb |
Perputaran | 4,18 jt | 120,01 jt |
Harga Rata-rata | 207,72 | 146,84 |
Nilai Transaksi | 4,18 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 208 | 146 |
Volume Ekuilibrium Indikatif | 13,8 rb | 59 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Budi Starch Sweetener Tbk
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Selengkapnya di halaman BUDI →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
